Loading…
Based on limited metadata, this warning letter was issued to JRB Enterprise Group Inc., which operates under the trade name "Anti Aging Bed," for violations related to drug products. The FDA classified the product as a drug rather than a device or cosmetic, indicating the company made therapeutic claims that exceeded permissible marketing boundaries. Without access to the full letter text, the specific nature of the violations cannot be detailed, though they likely involve unapproved drug claims or manufacturing/labeling deficiencies typical of anti-aging product enforcement actions.